Cargando…

Diarylethene‐Based Photoswitchable Inhibitors of Serine Proteases

A bicyclic peptide scaffold was chemically adapted to generate diarylethene‐based photoswitchable inhibitors of serine protease Bos taurus trypsin 1 (T1). Starting from a prototype molecule—sunflower trypsin inhibitor‐1 (SFTI‐1)—we obtained light‐controllable inhibitors of T1 with K(i) in the low na...

Descripción completa

Detalles Bibliográficos
Autores principales: Babii, Oleg, Afonin, Sergii, Diel, Christian, Huhn, Marcel, Dommermuth, Jennifer, Schober, Tim, Koniev, Serhii, Hrebonkin, Andrii, Nesterov‐Mueller, Alexander, Komarov, Igor V., Ulrich, Anne S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519022/
https://www.ncbi.nlm.nih.gov/pubmed/34268844
http://dx.doi.org/10.1002/anie.202108847
_version_ 1784584362723901440
author Babii, Oleg
Afonin, Sergii
Diel, Christian
Huhn, Marcel
Dommermuth, Jennifer
Schober, Tim
Koniev, Serhii
Hrebonkin, Andrii
Nesterov‐Mueller, Alexander
Komarov, Igor V.
Ulrich, Anne S.
author_facet Babii, Oleg
Afonin, Sergii
Diel, Christian
Huhn, Marcel
Dommermuth, Jennifer
Schober, Tim
Koniev, Serhii
Hrebonkin, Andrii
Nesterov‐Mueller, Alexander
Komarov, Igor V.
Ulrich, Anne S.
author_sort Babii, Oleg
collection PubMed
description A bicyclic peptide scaffold was chemically adapted to generate diarylethene‐based photoswitchable inhibitors of serine protease Bos taurus trypsin 1 (T1). Starting from a prototype molecule—sunflower trypsin inhibitor‐1 (SFTI‐1)—we obtained light‐controllable inhibitors of T1 with K(i) in the low nanomolar range, whose activity could be modulated over 20‐fold by irradiation. The inhibitory potency as well as resistance to proteolytic degradation were systematically studied on a series of 17 SFTI‐1 analogues. The hydrogen bond network that stabilizes the structure of inhibitors and possibly the enzyme–inhibitor binding dynamics were affected by isomerization of the photoswitch. The feasibility of manipulating enzyme activity in time and space was demonstrated by controlled digestion of gelatin‐based hydrogel and an antimicrobial peptide BP100‐RW. Finally, our design principles of diarylethene photoswitches are shown to apply also for the development of other serine protease inhibitors.
format Online
Article
Text
id pubmed-8519022
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85190222021-10-21 Diarylethene‐Based Photoswitchable Inhibitors of Serine Proteases Babii, Oleg Afonin, Sergii Diel, Christian Huhn, Marcel Dommermuth, Jennifer Schober, Tim Koniev, Serhii Hrebonkin, Andrii Nesterov‐Mueller, Alexander Komarov, Igor V. Ulrich, Anne S. Angew Chem Int Ed Engl Communications A bicyclic peptide scaffold was chemically adapted to generate diarylethene‐based photoswitchable inhibitors of serine protease Bos taurus trypsin 1 (T1). Starting from a prototype molecule—sunflower trypsin inhibitor‐1 (SFTI‐1)—we obtained light‐controllable inhibitors of T1 with K(i) in the low nanomolar range, whose activity could be modulated over 20‐fold by irradiation. The inhibitory potency as well as resistance to proteolytic degradation were systematically studied on a series of 17 SFTI‐1 analogues. The hydrogen bond network that stabilizes the structure of inhibitors and possibly the enzyme–inhibitor binding dynamics were affected by isomerization of the photoswitch. The feasibility of manipulating enzyme activity in time and space was demonstrated by controlled digestion of gelatin‐based hydrogel and an antimicrobial peptide BP100‐RW. Finally, our design principles of diarylethene photoswitches are shown to apply also for the development of other serine protease inhibitors. John Wiley and Sons Inc. 2021-08-25 2021-09-27 /pmc/articles/PMC8519022/ /pubmed/34268844 http://dx.doi.org/10.1002/anie.202108847 Text en © 2021 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Communications
Babii, Oleg
Afonin, Sergii
Diel, Christian
Huhn, Marcel
Dommermuth, Jennifer
Schober, Tim
Koniev, Serhii
Hrebonkin, Andrii
Nesterov‐Mueller, Alexander
Komarov, Igor V.
Ulrich, Anne S.
Diarylethene‐Based Photoswitchable Inhibitors of Serine Proteases
title Diarylethene‐Based Photoswitchable Inhibitors of Serine Proteases
title_full Diarylethene‐Based Photoswitchable Inhibitors of Serine Proteases
title_fullStr Diarylethene‐Based Photoswitchable Inhibitors of Serine Proteases
title_full_unstemmed Diarylethene‐Based Photoswitchable Inhibitors of Serine Proteases
title_short Diarylethene‐Based Photoswitchable Inhibitors of Serine Proteases
title_sort diarylethene‐based photoswitchable inhibitors of serine proteases
topic Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519022/
https://www.ncbi.nlm.nih.gov/pubmed/34268844
http://dx.doi.org/10.1002/anie.202108847
work_keys_str_mv AT babiioleg diarylethenebasedphotoswitchableinhibitorsofserineproteases
AT afoninsergii diarylethenebasedphotoswitchableinhibitorsofserineproteases
AT dielchristian diarylethenebasedphotoswitchableinhibitorsofserineproteases
AT huhnmarcel diarylethenebasedphotoswitchableinhibitorsofserineproteases
AT dommermuthjennifer diarylethenebasedphotoswitchableinhibitorsofserineproteases
AT schobertim diarylethenebasedphotoswitchableinhibitorsofserineproteases
AT konievserhii diarylethenebasedphotoswitchableinhibitorsofserineproteases
AT hrebonkinandrii diarylethenebasedphotoswitchableinhibitorsofserineproteases
AT nesterovmuelleralexander diarylethenebasedphotoswitchableinhibitorsofserineproteases
AT komarovigorv diarylethenebasedphotoswitchableinhibitorsofserineproteases
AT ulrichannes diarylethenebasedphotoswitchableinhibitorsofserineproteases